John Onopchenko — Chief Operating Officer at Endologix

Mr. John Onopchenko has been an Executive Vice President of Strategy, Business Development and Integrations at Volcano Corporation since May 2013. Mr. Onopchenko is the Managing Director of Synergy Life Science Partners L.P and Synergy Life Science Partners. He has been the Chief Operating Officer of Endologix, Inc. since October 30, 2017. He served as Vice President of Johnson & Johnson Development Corporation from 2000 to 2006. Mr. Onopchenko serves as a Director of Coraz???n Technologies, Inc. and OCTANe. He has been a Director of InnerPulse, Inc. since January 30, 2007. Mr. Onopchenko serves as a Director of Symphony Medical, Inc., OCTANe LLC, Corthera Inc., GI Dynamics, Inc., Symphony Medical, Inc., USGI Medical, Inc. and Vascular Control Systems, Inc. He serves as a Member of the Board of Directors of Barosense, Inc. He served as Director of TransEnterix, Inc., He served as a Member of Advisory Board of Ferrer Freeman & Company, LLC. Mr. Onopchenko served as a Director of Oraya Therapeutics, Inc., NuVasive, Inc., CardioPolymers, Inc., CardioVention, Inc., Arbor Surgical Technologies Inc., Corazon Technologies, Inc., Vivant Medical, Inc. and Orqis Medical Corporation. He served as a Director of Synecor, LLC. He has been a Director of Volcano Corporation from June 6, 2007 to March 29, 2013 and previously from 2002 to 2006. He serves as a Member of the Licensing Executive Society and a registered representative with the National Association of Securities Dealers. Mr. Onopchenko completed the Advanced Management Program at Oxford. He holds Masters in Business from the University of Chicago, Graduate School of Business and a B.S. from Ursinus College.